JMBM served as legal counsel to Intravenous Therapy Services in the $13 million sale of the company to BioScrip Inc. The Burbank, Calif.-based home infusion pharmaceutical provider will operate under publicly held BioScrip’s infusion division, but will continue to be run by its current president and CEO.
When the collective bargaining agreement between our Los Angeles client Good Samaritan Hospital and more than 450 unionized healthcare workers came up for renewal, a group of hospital employees petitioned the National Labor Relations Board (NLRB) for an election to decertify the union. In a subsequent secret-ballot election, the union held on to its representation […]
We filed suit on behalf of our client Cancer Therapeutics Laboratories (CTL), a California-based biopharmaceutical company, against a former joint venture partner in a licensing dispute over Tumor Necrosis Therapy (TNT), an antibody technology that locates and kills cancer cells. The licensing agreement between the two partners stipulated that CTL’s research results and products using […]
JMBM served as legal counsel for the sale of a neonatal physician group based in Lancaster, California, to Pediatrix Medical Group, Inc. (NYSE: PDX), a leading provider of neonatal, fetal and pediatric subspecialty physician services. Our client joined the 860 doctors and 350 nurse practitioners in 32 states that work with Pediatrix. The sale involved […]